Filing Details
- Accession Number:
- 0001415889-24-028069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:11:42
- Reporting Period:
- 2024-12-01
- Accepted Time:
- 2024-12-03 16:11:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623526 | Stoke Therapeutics Inc. | STOK | Pharmaceutical Preparations (2834) | 471144582 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780088 | Barry Ticho | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-01 | 48,792 | $0.00 | 51,277 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 10,000 | $0.60 | 61,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 10,000 | $12.07 | 51,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-12-01 | 48,792 | $0.00 | 48,792 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 10,000 | $0.00 | 10,000 | $0.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,981 | 2025-12-01 | No | 4 | M | Direct | |
| 0 | 2028-04-02 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2023.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.81 to $12.28 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- 48,792 restricted stock units vest on December 1, 2024 and 11,981 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.
- This fully-vested option vested as to 1/4th of the total award on October 2, 2018, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
Billionaire Hedge Funds
